CONVERSIO HEALTH, LLC

Profile

Company Names

CONVERSIO HEALTH, LLC

Addresses

720 AEROVISTA PLACE, SUITE D, SAN LUIS OBISPO, CA 93401

RESEARCH FOREST LAKESIDE BUILDING 4, 2445 TECHNOLOGY FOREST BLVD., SUITE 220, THE WOODLANDS, TX 77381

Phone Numbers

3463201207
281-419-8825

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

OTHER HEALTH CARE, PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$39,019,796.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2024-01-27 
$20,273,660.00 
$25,000,000.00 
$4,726,340.00 
Equity 
2
2020-10-14 
$3,921,136.00 
$5,000,000.00 
$1,078,864.00 
Equity 
1
2013-09-13 
$14,825,000.00 
$17,325,000.00 
$2,500,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
AMANDA 
 
BRINGE 
EXECUTIVE OFFICER
PAT 
 
CLINE 
DIRECTOR
PATRICK 
 
CLINE 
DIRECTOR
TAYLOR 
 
CLINE 
EXECUTIVE OFFICER, DIRECTOR
KIRK 
 
CLOVE 
EXECUTIVE OFFICER, DIRECTOR
CHRISTOPHER 
 
DOOLEY 
EXECUTIVE OFFICER
MATT 
 
ETHERIDGE 
DIRECTOR
MATTHEW 
 
ETHERIDGE 
DIRECTOR
DYLAN 
 
HERR 
EXECUTIVE OFFICER
MICHAEL 
 
HOLOHAN 
EXECUTIVE OFFICER
JAMES 
 
HOXTER 
DIRECTOR
DEVRAJ 
 
MUKHERJEE 
EXECUTIVE OFFICER
BARTHO 
 
VAN OTTERDYK 
EXECUTIVE OFFICER
SCOTT 
 
WADDELL 
EXECUTIVE OFFICER
CHRISTOPHER 
 
WOOLEY 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-27 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-27 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-27 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#